Outlook Therapeutics OTLK
NASDAQ OTLK
$0.58 +0.01 (+1.48%)
As of: Oct 1, 2026 · 3:59 PM EDT

Outlook Therapeutics (OTLK) Other Operating Expenses (2018 - 2020)

Updated

Outlook Therapeutics (OTLK) reported Other Operating Expenses of $527,624 for FY2020 (year ended Sep 30, 2020), down 95.3% from $11.27 million in FY2019.

Analysis

Outlook Therapeutics (OTLK) Other Operating Expenses (2018 - 2020) Analysis & Trends

  • According to Business Quant data, Other Operating Expenses came in at $11.27 million in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Outlook Therapeutics 77.94 Mn 42.19 Mn -8,265.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2020 104,296.00
Mar 31, 2020 423,328.00
Sep 30, 2019 8.31 Mn
Jun 30, 2019 50,927.00
Mar 31, 2019 561,735.00
Dec 31, 2018 2.35 Mn
API Access

Outlook Therapeutics Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=OTLK&period=max&api_key=YOUR_API_KEY